Dana-Farber Cancer Center

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Dana-Farber Cancer Center
Dec 12, 2024, 16:51 | Insight
Insights from SABCS24 by Matteo Lambertini
The San Antonio Breast Cancer Symposium (SABCS) 2024 is taking place from December 10-13 in…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Nov 28, 2024, 00:11 | Blog
ALCSI - Distinguished Lecture Series Event with Dr. Narjust Florez
ALCSI shared on X: "We are so excited for our Distinguished Lecture Series Event at 7…
Oct 12, 2024, 12:43 | Blog
The 7th Annual B-PREP Patient Forum - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Join us on Sat, Oct 19th, 9…
Oct 10, 2024, 09:24 | Blog
Alan Rubin: Looking forward to my 4th Jimmy Fund Walk with
Alan Rubin shared a post on X: "Special day, for so many reasons. Already looking forward…
Oct 9, 2024, 14:10 | Stories
David Thau's Journey with Colon Cancer: From Patient to Advocate
What motivated David Thau to become one of the top fundraisers? David Thau is recognized…
Oct 6, 2024, 16:57 | Blog
Sarah Sammons: Sound advice on how to help a friend with cancer
Sarah Sammons shared a post on X: "I am very lucky to know Renée and she…
Oct 2, 2024, 14:56 | Insight
The most recent Breast Cancer Research Digest by Dana-Farber
Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the most recent Breast Cancer…
Sep 24, 2024, 12:29 | Blog
Caterina Sposetti: Excess weight and risk of 2nd primary tumors in early-stage cancer survivors
Caterina Sposetti, Medical Oncology Fellow, Dana-Farber Cancer Center, shared a post on X: "New interesting…
Sep 14, 2024, 15:42 | Blog
Lauren Merz: A brilliant piece on a nuanced subject that impacts millions of people
Lauren Merz, Hemat/onc fellow at Dana-Farber Institute, shared a post on X: "Cheers to STAT News…
Sep 14, 2024, 15:33 | Insight
Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma
Toni Choueiri shared a post on X about a recent paper by Brian Shuch et…
Sep 9, 2024, 11:13 | Insight
Benjamin Ebert is the New President and CEO of Dana-Farber Cancer Center
Benjamin Ebert, MD, PhD chair of Department of Medical Oncology at the Dana-Farber Cancer Center…
Sep 8, 2024, 02:35 | Career
The New President and CEO of Dana-Farber Cancer Center - Benjamin Ebert
Benjamin Ebert, MD, PhD chair of Department of Medical Oncology at the Dana-Farber Cancer Center…
Aug 5, 2024, 14:36 | Blog
George Demetri: What an amazing day at PMC2024
George Demetri, Director of the Ludwig Center at Dana-Farber/Harvard Cancer Center, shared on X: "PMC2024…
Jul 25, 2024, 11:12 | Societies
8 Posts From ANZUP24 That You Should Not Miss!
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) organized their ANZUP24 Annual…
Jul 13, 2024, 12:22 | Insight
Key Highlights from KCRS24 by Sumanta K. Pal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in Boston focused…
Jul 12, 2024, 20:47 | Societies
Stuart Schnitt on the future of breast pathology with the potential benefits of AI
Sara Tolaney shared on X: "Dr Stuart Schnitt does an outstanding job highlighting the future…
Jun 20, 2024, 07:36 | Blog
LGBTQ+ patients report on their cancer care journey
Estela Rodriguez shared a post on X: "Disparities uncovered: LGBTQ+ patients report on their cancer care…
Apr 28, 2024, 21:10 | Drugs
Doug Rubinson: The best drug in GI cancers is 5-FU
Doug Rubinson, GI Medical Oncologist At Dana-Farber Cancer Centre, shared on X/Twitter: "In oncology, we…
Apr 12, 2024, 16:30 | Insight
Douglas Flora: NEJM AI and the team at Dana-Farber Cancer Center just published a great case study in which they revealed some insights following the (careful) deployment of generative AI
Apr 8, 2024, 14:26 | Drugs
Dana-Farber’s Breast Oncology Center is leading a trial for stage 1 HER2+ Breast Cancer of T-DM1 followed by SQ trastuzumab versus TH
Dana-Farber’s Breast Oncology Center posted on X: "We are leading a randomized Phase 2 trial for…
Mar 27, 2024, 14:24 | Blog
Elad Sharon: A great honor to speak at The Tisch Cancer Institute this week at Hematology Oncology Grand Rounds
Elad Sharon, Clinical and Translational Director at Dana-Farber Cancer Institute, shared a post by The Tisch Cancer Institute,…
Mar 16, 2024, 20:43 | Insight
Humaid Al-Shamsi: Pleased to share with you our latest 2 publications published on the same day about lung cancer
Humaid Al-Shamsi, Director of Burjeel Cancer Institute Comprehensive Cancer Center and Burjeel Holdings Oncology UAE,…
Nov 4, 2023, 00:39 | Opinion
Narjust Florez: Discharge is the time when patients are most vulnerable
Narjust Florez shared in Twitter: "Discharge is the time when patients are most vulnerable. A…
All: 24 Posts: 1 - 100
Special Coverage